{"transactions":[{"id":1297293,"issuer":{"id":6276,"kind":"organization","name":"Coherus Oncology, Inc."},"owners":[{"id":83970,"kind":"person","name":"Reider Paul","position":1,"cik":"0001970033","reported_name":"Reider Paul","relationship":{"officer":true,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2025-01-23T00:49:54.000Z","date":"2025-01-20","kind":"tax_withholding","planned":false,"acquired":false,"shares":4858,"price":1.39,"value":6752.62,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares automatically withheld by the Issuer to pay related tax liability in connection with the vesting of restricted stock units in accordance with Rule 16b-3. No shares were sold by the Reporting Person in connection with the foregoing transaction."}],"balance_after":82069,"source":{"system":"sec-edgar","filing":"0001610717-25-000014","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1512762/000161071725000014/form4.xml","form_type":"4"}},{"id":1307625,"issuer":{"id":6276,"kind":"organization","name":"Coherus Oncology, Inc."},"owners":[{"id":83970,"kind":"person","name":"Reider Paul","position":1,"cik":"0001970033","reported_name":"Reider Paul","relationship":{"officer":true,"officer_title":"Chief Commercial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-01-08T01:50:18.000Z","date":"2025-01-03","kind":"grant","planned":false,"acquired":true,"shares":160000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The underlying shares subject to the option vest and become exercisable as to 1/4th of the total number of shares on the one year anniversary of January 3, 2025 and 1/48th of the total number of shares in successive, equal monthly installments thereafter, subject to Reporting Person's continued service relationship with the Issuer on each such vesting date."}],"balance_after":160000,"derivative":{"exercise_price":1.66,"expiration_date":"2035-01-03","underlying":"Common Stock","underlying_shares":160000},"source":{"system":"sec-edgar","filing":"0001610717-25-000007","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1512762/000161071725000007/form4.xml","form_type":"4"}},{"id":1307624,"issuer":{"id":6276,"kind":"organization","name":"Coherus Oncology, Inc."},"owners":[{"id":83970,"kind":"person","name":"Reider Paul","position":1,"cik":"0001970033","reported_name":"Reider Paul","relationship":{"officer":true,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2025-01-08T01:50:18.000Z","date":"2025-01-04","kind":"tax_withholding","planned":false,"acquired":false,"shares":2277,"price":1.66,"value":3779.82,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares automatically withheld by the Issuer to pay related tax liability in connection with the vesting of restricted stock units in accordance with Rule 16b-3. No shares were sold by the Reporting Person in connection with the foregoing transaction."}],"balance_after":86927,"source":{"system":"sec-edgar","filing":"0001610717-25-000007","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1512762/000161071725000007/form4.xml","form_type":"4"}},{"id":1328207,"issuer":{"id":6276,"kind":"organization","name":"Coherus Oncology, Inc."},"owners":[{"id":83970,"kind":"person","name":"Reider Paul","position":1,"cik":"0001970033","reported_name":"Reider Paul","relationship":{"officer":true,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2024-12-17T21:44:12.000Z","date":"2024-12-13","kind":"tax_withholding","planned":false,"acquired":false,"shares":2073,"price":1.61,"value":3337.53,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares automatically withheld by the Issuer to pay related tax liability in connection with the vesting of restricted stock units in accordance with Rule 16b-3. No shares were sold by the Reporting Person in connection with the foregoing transaction."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 5,000 shares acquired on November 15, 2024 and 5,000 shares acquired on May 15, 2024, each pursuant to the Coherus BioSciences, Inc. Employee Stock Purchase Plan."}],"balance_after":89204,"source":{"system":"sec-edgar","filing":"0001610717-24-000542","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1512762/000161071724000542/form4.xml","form_type":"4"}},{"id":1449239,"issuer":{"id":6276,"kind":"organization","name":"Coherus Oncology, Inc."},"owners":[{"id":83970,"kind":"person","name":"Reider Paul","position":1,"cik":"0001970033","reported_name":"Reider Paul","relationship":{"officer":true,"officer_title":"Chief Commercial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-07-25T00:14:40.000Z","date":"2024-07-22","kind":"grant","planned":false,"acquired":true,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"On April 11, 2024 the Reporting Person was granted a performance stock option to purchase 200,000 shares of common stock, of which 40,000 of the shares vested and became exercisable on July 22, 2024 in connection with the Closing of the sale of Coherus BioSciences, Inc.'s YUSIMRY franchise."}],"balance_after":40000,"derivative":{"exercise_price":2.41,"expiration_date":"2034-04-11","underlying":"Common Stock","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0001610717-24-000405","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1512762/000161071724000405/form4.xml","form_type":"4"}},{"id":1672750,"issuer":{"id":6276,"kind":"organization","name":"Coherus Oncology, Inc."},"owners":[{"id":83970,"kind":"person","name":"Reider Paul","position":1,"cik":"0001970033","reported_name":"Reider Paul","relationship":{"officer":true,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2024-01-24T01:05:42.000Z","date":"2024-01-20","kind":"tax_withholding","planned":false,"acquired":false,"shares":4854,"price":2.44,"value":11843.76,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares automatically withheld by the Issuer to pay related tax liability in connection with the vesting of restricted stock units in accordance with Rule 16b-3. No shares were sold by the Reporting Person in connection with the foregoing transaction."}],"balance_after":81277,"source":{"system":"sec-edgar","filing":"0001610717-24-000038","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1512762/000161071724000038/form4.xml","form_type":"4"}},{"id":1683804,"issuer":{"id":6276,"kind":"organization","name":"Coherus Oncology, Inc."},"owners":[{"id":83970,"kind":"person","name":"Reider Paul","position":1,"cik":"0001970033","reported_name":"Reider Paul","relationship":{"officer":true,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2024-01-08T23:58:36.000Z","date":"2024-01-04","kind":"tax_withholding","planned":false,"acquired":false,"shares":2275,"price":2.92,"value":6643.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares automatically withheld to pay related tax liability in connection with the vesting of restricted stock units in accordance with Rule 16b-3."}],"balance_after":86131,"source":{"system":"sec-edgar","filing":"0001610717-24-000018","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1512762/000161071724000018/form4.xml","form_type":"4"}},{"id":1687130,"issuer":{"id":6276,"kind":"organization","name":"Coherus Oncology, Inc."},"owners":[{"id":83970,"kind":"person","name":"Reider Paul","position":1,"cik":"0001970033","reported_name":"Reider Paul","relationship":{"officer":true,"officer_title":"Chief Commercial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-01-04T22:13:16.000Z","date":"2024-01-02","kind":"grant","planned":false,"acquired":true,"shares":160000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/48th of the total number of shares subject to the option shall vest in successive, equal monthly installments measured from January 2, 2024, subject to Reporting Person's continued service relationship with the Issuer on each such vesting date."}],"balance_after":160000,"derivative":{"exercise_price":3.14,"expiration_date":"2034-01-02","underlying":"Common Stock","underlying_shares":160000},"source":{"system":"sec-edgar","filing":"0001610717-24-000011","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1512762/000161071724000011/form4.xml","form_type":"4"}},{"id":1708854,"issuer":{"id":6276,"kind":"organization","name":"Coherus Oncology, Inc."},"owners":[{"id":83970,"kind":"person","name":"Reider Paul","position":1,"cik":"0001970033","reported_name":"Reider Paul","relationship":{"officer":true,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2023-12-15T21:47:23.000Z","date":"2023-12-13","kind":"tax_withholding","planned":false,"acquired":false,"shares":2049,"price":2.37,"value":4856.13,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares automatically withheld to pay related tax liability in connection with the vesting of restricted stock units in accordance with Rule 16b-3."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 3,402 shares acquired on May 15, 2023 pursuant to the Coherus BioSciences, Inc. Employee Stock Purchase Plan."}],"balance_after":88406,"source":{"system":"sec-edgar","filing":"0001610717-23-000401","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1512762/000161071723000401/form4.xml","form_type":"4"}},{"id":1853957,"issuer":{"id":6276,"kind":"organization","name":"Coherus Oncology, Inc."},"owners":[{"id":83970,"kind":"person","name":"Reider Paul","position":1,"cik":"0001970033","reported_name":"Reider Paul","relationship":{"officer":true,"officer_title":"Chief Commercial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-06-15T20:39:54.000Z","date":"2023-06-13","kind":"grant","planned":false,"acquired":true,"shares":70000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The underlying shares subject to the option vest and become exercisable as to 50% of the shares on each anniversary measured from June 13, 2023, subject to Reporting Person's continued service relationship with the Issuer on each such vesting date."}],"balance_after":70000,"derivative":{"exercise_price":5.44,"expiration_date":"2033-06-13","underlying":"Common Stock","underlying_shares":70000},"source":{"system":"sec-edgar","filing":"0001610717-23-000165","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1512762/000161071723000165/form4.xml","form_type":"4"}},{"id":1927016,"issuer":{"id":6276,"kind":"organization","name":"Coherus Oncology, Inc."},"owners":[{"id":83970,"kind":"person","name":"Reider Paul","position":1,"cik":"0001970033","reported_name":"Reider Paul","relationship":{"officer":true,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2023-04-05T00:57:52.000Z","date":"2023-04-01","kind":"tax_withholding","planned":false,"acquired":false,"shares":2451,"price":6.84,"value":16764.84,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares automatically withheld to pay related tax liability in connection with the vesting of restricted stock units in accordance with Rule 16b-3."}],"balance_after":87053,"source":{"system":"sec-edgar","filing":"0001140361-23-016454","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1512762/000114036123016454/form4.xml","form_type":"4"}}]}